Regulatory T cell dysfunction in type 1 diabetes: what's broken and how can we fix it?
about
Translating Mechanism of Regulatory Action of Tolerogenic Dendritic Cells to Monitoring Endpoints in Clinical Trials.Approaches in Immunotherapy, Regenerative Medicine, and Bioengineering for Type 1 Diabetes.Regulatory T Cells in Systemic SclerosisAbnormal T Cell Frequencies, Including Cytomegalovirus-Associated Expansions, Distinguish Seroconverted Subjects at Risk for Type 1 DiabetesTherapies to Suppress β Cell Autoimmunity in Type 1 Diabetes
P2860
Regulatory T cell dysfunction in type 1 diabetes: what's broken and how can we fix it?
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Regulatory T cell dysfunction in type 1 diabetes: what's broken and how can we fix it?
@en
type
label
Regulatory T cell dysfunction in type 1 diabetes: what's broken and how can we fix it?
@en
prefLabel
Regulatory T cell dysfunction in type 1 diabetes: what's broken and how can we fix it?
@en
P2860
P1433
P1476
Regulatory T cell dysfunction in type 1 diabetes: what's broken and how can we fix it?
@en
P2093
Caroline M Hull
P2860
P2888
P304
P356
10.1007/S00125-017-4377-1
P577
2017-08-02T00:00:00Z